Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Cited In for PubMed (Select 11809180)

1.
2.

Approach to Helicobacter pylori infection in geriatric population.

Cizginer S, Ordulu Z, Kadayifci A.

World J Gastrointest Pharmacol Ther. 2014 Aug 6;5(3):139-47. doi: 10.4292/wjgpt.v5.i3.139. Review.

3.

Estimates of benefits and harms of prophylactic use of aspirin in the general population.

Cuzick J, Thorat MA, Bosetti C, Brown PH, Burn J, Cook NR, Ford LG, Jacobs EJ, Jankowski JA, La Vecchia C, Law M, Meyskens F, Rothwell PM, Senn HJ, Umar A.

Ann Oncol. 2015 Jan;26(1):47-57. doi: 10.1093/annonc/mdu225. Epub 2014 Aug 5. Review.

4.

Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights.

Sostres C, Gargallo CJ, Lanas A.

World J Gastroenterol. 2014 Jul 28;20(28):9439-50. doi: 10.3748/wjg.v20.i28.9439. Review.

5.

COX-2 Gene Promoter Methylation in Patients Infected with Helicobacter Pylori.

Michikawa Y, Yasuda H, Watanabe Y, Oikawa R, Ohishi Y, Maehata T, Itoh F.

Clin Med Insights Gastroenterol. 2013 Jun 25;6:13-9. doi: 10.4137/CGast.S11917. eCollection 2013.

6.

Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage.

Sostres C, Gargallo CJ, Lanas A.

Arthritis Res Ther. 2013;15 Suppl 3:S3. doi: 10.1186/ar4175. Epub 2013 Jul 24. Review.

7.

Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazole.

Tang RS, Wu JC.

Clin Interv Aging. 2013;8:1433-43. doi: 10.2147/CIA.S41350. Epub 2013 Oct 25. Review.

8.

Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance.

Brooks J, Warburton R, Beales IL.

Ther Adv Chronic Dis. 2013 Sep;4(5):206-22. doi: 10.1177/2040622313492188.

9.

Cost Effectiveness Associated with Helicobacter pylori Screening and Eradication in Patients Taking Nonsteroidal Anti-Inflammatory Drugs and/or Aspirin.

Song HJ, Kwon JW, Kim N, Park YS.

Gut Liver. 2013 Mar;7(2):182-9. doi: 10.5009/gnl.2013.7.2.182. Epub 2013 Mar 14.

10.

Assessment of Helicobacter pylori eradication in patients on NSAID treatment.

Vonkeman HE, Deleest H, van Delaar M, Vanbaarlen J, Steen K, Lems W, Bijlsma J, Kuipers E, Houben H, Janssen M, Dijkmans B.

BMC Gastroenterol. 2012 Sep 24;12:133. doi: 10.1186/1471-230X-12-133.

11.

A fibreoptic endoscopic study of upper gastrointestinal bleeding at Bugando Medical Centre in northwestern Tanzania: a retrospective review of 240 cases.

Jaka H, Koy M, Liwa A, Kabangila R, Mirambo M, Scheppach W, Mkongo E, McHembe MD, Chalya PL.

BMC Res Notes. 2012 Jul 3;5:200. doi: 10.1186/1756-0500-5-200.

12.

Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model.

Kotiw M, Johnson M, Pandey M, Fry S, Hazell SL, Netter HJ, Good MF, Olive C.

Clin Vaccine Immunol. 2012 Feb;19(2):268-76. doi: 10.1128/CVI.05295-11. Epub 2011 Dec 28.

13.

Acid peptic diseases: pharmacological approach to treatment.

Mejia A, Kraft WK.

Expert Rev Clin Pharmacol. 2009 May;2(3):295-314.

14.

Helicobacter pylori infection.

Leontiadis GI, Moayyedi P, Ford AC.

BMJ Clin Evid. 2009 Oct 1;2009. pii: 0406.

15.

Efficacy of serology driven "test and treat strategy" for eradication of H. pylori in patients with rheumatic disease in the Netherlands.

de Leest HT, Steen KS, Lems WF, van de Laar MA, Huisman AM, Kadir SW, Houben HH, Kostense PJ, Kuipers EJ, Dijkmans BA, Debets-Ossenkopp YJ.

Eur J Clin Microbiol Infect Dis. 2011 Jul;30(7):903-8. doi: 10.1007/s10096-011-1174-5. Epub 2011 Feb 4.

16.

Celecoxib inhibits Helicobacter pylori colonization-related factors.

Wang J, Wang WH, Li J, Liu FX.

World J Gastroenterol. 2010 Feb 21;16(7):846-53.

17.

Helicobacter pylori: present status and future prospects in Japan.

Suzuki H, Hibi T, Marshall BJ.

J Gastroenterol. 2007 Jan;42(1):1-15. Epub 2007 Feb 16. Review.

18.

Ageing and the gut.

D'Souza AL.

Postgrad Med J. 2007 Jan;83(975):44-53. Review.

19.

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ.

Gut. 2007 Jun;56(6):772-81. Epub 2006 Dec 14.

20.

Pathogenesis of Helicobacter pylori infection.

Kusters JG, van Vliet AH, Kuipers EJ.

Clin Microbiol Rev. 2006 Jul;19(3):449-90. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk